Welcome to our dedicated page for AXON ENTERPRISE SEC filings (Ticker: AXON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AXON ENTERPRISE's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AXON ENTERPRISE's regulatory disclosures and financial reporting.
Axon Enterprise, Inc. chief revenue officer Cameron Brooks reported an open-market sale of Common Stock. On June 4, 2026, he sold 1,242 shares at a price of $500.00 per share. Following this transaction, he directly holds 49,709.933 shares of Axon Common Stock.
According to a footnote, this sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025, indicating the trade was scheduled in advance rather than timed discretionarily.
AXON ENTERPRISE, INC. chief executive officer Patrick W. Smith reported an open-market sale of 20,000 shares of common stock at $500.00 per share. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 12, 2025. Following this sale, Smith directly holds 3,060,997 shares of Axon common stock.
Axon Enterprise, Inc. notice of proposed sale of 13,000 shares of common stock through Wells Fargo Clearing Services on 06/05/2026. The filing shows a dollar amount of $6,349,359.92 associated with that row and Nasdaq as the trading market. The excerpt also lists prior RSU issuances (examples shown) of 7,306, 18,654, 17,156, and 12,363 shares granted on the dates shown. A selling-holder row reports 34,581 shares sold on 03/10/2026 with $18,478,587.82 reflected.
AXON notice of proposed sale under Form 144 filed through Morgan Stanley Smith Barney LLC. The filing lists 1,242 common stock units tied to Restricted Stock Units with an entry date of 05/31/2026 and shows an administrative record date of 06/04/2026. The filing also records a prior 10b5-1 sale by Cameron J. Brooks on 03/09/2026 showing 1,221 common units and a value figure of $690,487.71. This is a routine Form 144 notice of an intended resale by an affiliate; cash‑flow treatment and final sale mechanics are not included in the excerpt.
AXON filed a Form 144 reporting proposed sales of Common stock under compensation arrangements. The notice lists 915 shares tied to Performance Stock Units with a 12/01/2025 reference and 639 shares tied to Restricted Stock Vesting Under a Registered Plan with a 05/31/2026 reference. The brokerage firm listed is Morgan Stanley Smith Barney LLC and the market is identified as NASDAQ.
AXON submitted a notice under Section 144 for the proposed sale of 20,000 common shares. The filing lists the method as Option Exercise with a related date of 11/15/2021. The filing also discloses that Patrick W. Smith sold 10,000 common shares on 03/09/2026 for $5,602,394.00.
AXON ENTERPRISE, INC. Chief Accounting Officer Jennifer H. Mak reported two transactions in common stock tied to tax withholding. On June 1, 2026, a total of about 2,223.9 shares were disposed of to cover tax liabilities from the vesting of restricted stock units under Axon’s equity plans. These are administrative, non–open-market dispositions and do not represent discretionary share sales.
AXON ENTERPRISE, INC. Chief Product & Technology Officer Jeffrey C. Kunins reported a routine tax-related share withholding tied to vesting of performance-based restricted stock units. On June 1, 2026, 8,113.183 shares of common stock at $476.88 per share were disposed of to settle his tax liability from the vesting of the third tranche of RSUs granted under the Axon Enterprise, Inc. 2024 eXponential Stock Plan.
Following this tax-withholding disposition, Kunins directly held 59,696.817 shares of Axon common stock. Separately, he indirectly owned 86,268 shares through an LLC of which he is the sole member. The Form 4 does not show any open-market purchases or sales, only the tax withholding and updated holdings.
AXON ENTERPRISE, INC. COO & CFO Brittany Bagley reported an open-market sale of 5,969 shares of common stock on June 2, 2026 at $485.00 per share. After this transaction, she directly owned 77,084.479 shares of Axon common stock.
On June 1, 2026, 16,181.521 shares were disposed of at $476.88 per share to cover her tax liability from the vesting of the third tranche of restricted stock units granted under Axon’s 2024 eXponential Stock Plan, which is a tax-withholding event rather than an open-market sale.